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Purpose: To i) describe changes in health-related quality of life (HRQoL) preoperatively, at 
discharge, and four weeks after discharge following open heart surgery; ii) compare the 
performance of the EuroQol Questionnaire (EQ-5D 5L) and the Kansas City Cardiomyopathy 
Questionnaire (KCCQ) against an anchor-based approach and to iii) investigate the association 
between HRQoL and 180-day readmission. 
Methods: A prospective, consecutive cohort (single-center study) of 291 patients completed the 
EQ-5D 5L and KCCQ pre-operatively, at discharge and four weeks post-discharge. Changes in 
HRQoL over time were evaluated, and the performance of the instruments was investigated. The 
association between HRQoL and readmission were investigated with Cox Proportional Hazard 
models.  
Results: Scores of the EQ-5D Index and VAS decreased significantly from the preoperative 
assessment to discharge and improved from discharge to four weeks after. The KCCQ-scores 
significantly improved from baseline to four weeks after. Minimal clinically important 
improvements from before surgery to four weeks after were seen amongst 24% (EQ-5D Index), 
45% (EQ-5D VAS) and 57% (KCCQ). More than one-third experienced worse HRQoL one month 
after discharge. Area under the curve (AUC) (performance of the instruments) demonstrated; EQ-
5D Index AUC 0.622 (95% CI 0.540-0.704), VAS AUC 0.674 (95% CI 0.598-0.750) and KCCQ 
AUC 0.722 (95% CI 0.65-0.792). None of the HRQoL measurements were associated with 180-day 
readmission. 
Conclusions: This study revealed that HRQoL measured with the EQ-5D is significantly worse at 




EQ-5D and the KCCQ. The EQ-5D and KCCQ have a moderate correlation with an anchor-based 






The focus on improving patient quality of life and reducing symptoms after open heart valve 
surgery has gained prominence in the past decade. Due to advancements in surgical techniques, 
survival is no longer the only goal [1]. Although mortality rates are declining, patients continue to 
experience high readmission rates, increased symptom burden and changed bodily awareness in the 
early period after discharge. These are all factors that may adversely impact quality of life [2-4].  
Patient-reported outcomes, including measurements of health-related quality of life (HRQoL), 
symptom burden, physical and mental health, have increasingly been reported in studies and trials 
among patients undergoing open heart valve surgery [5-8]. In general, previous studies have 
demonstrated that patients undergoing open heart valve surgery report significantly impaired 
physical and mental health status before surgery, while improvements are not seen until three to six 
months post-operatively [9,10,6].  
A paucity of instruments have been validated to measure HRQoL in patients with heart valve 
disease and patients undergoing open heart valve surgery. These instruments include the generic 
EuroQol Questionnaire (EQ-5D) [11] and the disease-specific measures: HeartQoL [12], Kansas 
City Cardiomyopathy Questionnaire (KCCQ) [13], and Minnesota Living with Heart Failure 
Questionnaire (MLHFQ) [11]. However, none of these measures were explicitly developed for this 
population and not designed to capture changes from before and after open heart valve surgery. 
Previously, differences in performance of generic vs disease-specific instruments have been 
investigated comparing EQ-5D vs MLHFQ [11], but the performance of the KCCQ in patients 
undergoing open heart valve surgery is unknown. 
In other cardiac populations, poor self-reported health is known to be associated with worse long-
term outcomes (e.g., mortality, morbidity, and readmission) [14,15]. However, among patients 




different use of instruments, and low response rates make it difficult to determine the association 
between patient-reported outcomes and adverse events, such as readmission after heart valve 
surgery [5,18].  
Accordingly, more information on the specific instruments, their performance, and associations 
with adverse outcomes are needed. 
The overall aim of the current study was to strengthen the evidence of patient-reported outcomes in 
patients undergoing open heart valve surgery and thus, contribute to a shift in clinical care that 
incorporates the perspective of the patient. The specific objectives were to conduct a comprehensive 
study of i) changes in HRQoL pre-operatively, at discharge, and four weeks after discharge 
following open heart surgery; ii) comparison of the performance of KCCQ and EQ-5D against an 
anchor-based approach; and iii) the association between HRQoL and readmission within 180 days 
after discharge. 
Methods 
Study design and scope 
The current study is an exploratory outcome analysis of the Individualized Follow-up after Valve 
Surgery (INVOLVE) study [3]. The INVOLVE study was a prospective cohort single-center study 
investigating the effect of a multidisciplinary intervention consisting of early, individualized and 
intensified follow-up with a historical control group [3]. The primary analyses of the INVOLVE 
study demonstrated an effect of the intervention on a composite endpoint of the first event of 
unplanned readmissions or all-cause mortality within 180-days after discharge [3]. In the current 




Participants, setting and recruitment 
Data were collected at Odense University Hospital, Denmark, between November 1, 2016, and 
November 15, 2017. Patients undergoing open heart valve surgery (Nordic/NOMESCO surgical 
codes; Aorta (KFCA, KFMA, KFMC, KFMD), Mitral (KFKB, KFKC, KFKD, KDKW) and 
Tricuspid (KFGC, KFGE) were eligible for inclusion and were invited to complete a paper-based 
questionnaire pre-operatively (baseline, T0), at discharge (T1) and 4 weeks after discharge (T2). No 
patients were treated or referred to other institutions for management of pulmonary valve diseases 
during the period. 
Of the initial population of 308 patients, 17 were excluded due to language barriers, cognitive 
impairments and emergent status at the time of surgery (Figure 1). Furthermore, patients discharged 
without contact with the intervention staff did not receive the T1 questionnaire.  
Data collection 
Patient characteristics 
Demographic and clinical data were obtained from the electronic patient records, and the Western 
Denmark Heart Registry [19]. Data were entered into an electronic database (Research electronic 
data Capture, RedCap) hosted by Open Patient data Explorative Network (OPEN), Odense 
University Hospital [20].   
Readmission 
A readmission was defined as a) an admission occurring more than 24 hours after the index 
discharge, b) an overnight stay, c) a readmission occurring within the first 180-days after discharge 
(after surgery), and d) an unplanned readmission due to a presumed cardiac cause, or presumed 





We used the EQ-5D 5L and the KCCQ (12-item version) to assess HRQoL. The EQ-5D is a generic 
questionnaire consisting of two parts: The Index score and the Visual Analogue Scale, (VAS). The 
Index score covers five domains of health (mobility, self-care, activity, pain/discomfort and 
anxiety), where the patients are asked to rate the severity of each domain in five levels. A score of 1 
is considered to be full health and a score of 0 as being dead. The VAS is a graded, vertical 
thermometer type of measure anchored at 0 (worst QoL) and 100 (best QoL) [21,22]. The EQ-5D 
has shown high validity; it has previously been tested in a small sample of patients undergoing heart 
valve surgery [11]. Minimal clinically important differences (the smallest amount of benefit a 
patient can recognize [11,23]) of the EQ-5D has been reported to be 0.10 (Index score) and 8.61 
(VAS) in a population of patients receiving rehabilitation after stroke [23] and to be 0.125 (Index 
score) in a small study of patients undergoing heart valve surgery [11].  
The 12-item abbreviated version of the KCCQ[24] is a disease-specific health status questionnaire, 
derived from the 23-item KCCQ originally developed for patients with heart failure [24]. Currently, 
no disease-specific instruments have been developed for patients undergoing heart valve surgery, 
but the KCCQ has previously been validated in patients with severe aortic stenosis [13]. The KCCQ 
assesses four domains (physical limitation, symptom frequency, quality of life, and social 
limitation) that are combined into an overall summary score. The subscales and OS range from 0 to 
100, with higher scores indicating better health status and low symptom burden [24]. A minimal 
clinically important difference of 3 to 5 points for the KCCQ-12 OS has previously been proposed 
[24]. Improvements have been described as small (5 points), moderate (10-20 points) and large 
(>20 points) [25,26].  
We included a single question to capture the patient perspective of the overall outcome of the 




better than before surgery?” Possible answers were: “yes, feeling better”, “no, feeling worse” or 
“no change”. The simple anchor-based approach was used to compare the performance of the 
validated instruments EQ-5D and KCCQ. 
Patients completed the baseline questionnaire pre-operatively (T0, EQ-5D and KCCQ) in hospital 
prior to surgery and the second questionnaire (T1, EQ-5D) at the time of discharge from the 
surgical ward. KCCQ was not part of the T1, as the timing of discharge did not enable the 
requirement for measuring a two-week recall. The third and final questionnaire (T2, EQ-5D and 
KCCQ) was completed at the time of the four weeks consultation or within two days at home. No 
reminders were sent out.  
 
Statistical analyses 
Baseline characteristics and scores and numeric values of the EQ-5D and KCCQ are presented as 





(interquartile range, IQR), as appropriate.  
Due to the skewed distribution of both the EQ-5D and KCCQ scores, non-parametric tests were 
applied to analyze these data. Differences in median scores of the instruments EQ-5D pre-
operatively, at discharge and four weeks after discharge among the total group were tested with the 
Friedman test (paired), differences in scores of the KCCQ pre-operatively and four weeks after 
discharge were tested with the Wilcoxon signed-rank test (paired). Paired t-tests were used to 
analyze changes in mean scores in HRQoL at different time points. Categorical variables were 
compared using the χ
2 
test. Minimal clinically important differences were reported for all measures. 
Mean change on the instruments from before surgery to four weeks after discharge was divided into 




95% confidence intervals. Receiver operating characteristic (ROC) curves, the area under the curve 
(AUC), its associated 95% confidence intervals and the association with the anchor-based approach 
of feeling better than before surgery were generated for each instrument. The ROC curve plots the 
sensitivity of the instrument. 
Cox proportional hazards models were used to assess the association between HRQoL and hospital 
readmission. The worst quartile (0.691 preoperatively and 0.640 at discharge) of the EQ-5D Index 
score was included instead of the continuous score due to a non-linear increase in hazard rate with 
increasing scores. Each score of the instruments was investigated as a crude variable and adjusted 
for sex, age, type of valve procedure, concomitant coronary artery bypass grafting (CABG), 
reduced lung function, prior percutaneous coronary intervention and estimated glomerular filtration 
rate. Results are presented as hazard ratios (HR) with 95% confidence intervals (CI).  
Missing data (on the clinical variables) were considered to be missing completely at random, and 
thus, the analyses only included complete observations.   
A two-sided value of p<0.05 was considered significant. All statistical analyses were performed 
with the use of SPSS software, Version 24 (IBM Corp, Armonk, NY). 
 
Ethical considerations  
The investigation conformed with the principles outlined in the Declaration of Helsinki,[27] was 
approved by the Danish Data Protection Agency (18/19152), Danish Patient Safety Authority, and 
registered at ClinicalTrials.gov (NCT03053778). All patients received both written and oral 







Patient characteristics and health-related quality of life 
In total, 291 patients were eligible for inclusion in the study. Of the included patients, 241 (83%) 
and 245 (84%) completed the EQ-5D and the KCCQ, respectively, pre-operatively and four weeks 
post-discharge. In addition, 223 patients (77%) completed the EQ-5D at all three time-points 
(Figure 1). Demographic and clinical characteristics are summarized in Table 1. Of all patients, 
70% were men, the median age was 70 years, and 25% were living alone. Most patients were 
diagnosed with aortic stenosis (62%), followed by aortic regurgitation (19%) and mitral stenosis or 
regurgitation (19%) (Table 1). During the index admission, n=8 patients died (not eligible for 
inclusion). After discharge, 23% were readmitted. No patients died after discharge and during the 
four weeks follow-up, but two patients were lost to follow-up due to other reasons. 
There was a significant reduction in the EQ-5D Index and VAS scores between pre-operative 
assessment and discharge (EQ-5D Index ∆-0.06 (IQR -0.14-0.02, p<0.001) and VAS score ∆-4 
(IQR -20-10, p≤0.05)) and a significant increase between discharge and four weeks post-discharge 
(EQ-5D Index score ∆0.06 (IQR -0.02-0.13, p<0.001) and VAS score ∆11 (IQR 0-25, p<0.001)) 
(Table 2 and Figure 2). There was a significant improvement from pre-operatively to four weeks 
post-discharge for the EQ-5D VAS (∆7 (IQR -5;20, p<0.001)), but not for the EQ-5D Index Score 
∆0.00 (IQR -0.07-0.10, p=NS) (Figure 2).  
Patients reported significantly improved scores on the sub-scales of the KCCQ from baseline to four 
weeks, except for the “social limitation” sub-scale (Table 2). Similarly, from baseline to four weeks 
after discharge, the KCCQ OS-scores were significantly improved (∆11 (IQR -4-23, p<0.001)) 
(Figure 2). Figure 3 illustrates the temporal changes in categorical thresholds within each sub-scale 




Minimal clinically important differences  
On the EQ-5D, minimal clinically important improvements from pre-operatively to four weeks 
were seen among 24% (Index) and 45% (VAS) of the responders, whereas 42% (Index) and 30% 
(VAS) reported worse outcomes. Patients who did not have a minimal clinically important 
improvement were more likely to be ≥80 of age (EQ-5D, both scales), diagnosed with ischemic 
heart disease and have a history of previous percutaneous coronary intervention (PCI) (EQ-5D 
Index Score). On the KCCQ, a minimal clinically important difference (improvement) was seen in 
57% and observed as moderate (10-20 points) and large (>20 points) improvements in 19% and 
30%, respectively. Among responders, 32% experienced worse outcomes on the KCCQ after four 
weeks. Patients who did not experience a minimal clinically important improvement on the KCCQ 
were more likely to have ischemic heart disease and a history of a previous PCI. Overall, patients 
who reported scores in the worse quartile of each measurement pre-operatively did not report a 
minimal clinically important difference (data not shown). The concordance between the 
measurements and the ability to capture minimal clinically important differences were not similar, 
indicating that the same patient did not necessarily have a minimal clinically important difference 
on the KCCQ and the EQ-5D. 
The performance of EQ-5D and KCCQ on the anchor-based outcome   
In total, 285 patients answered the question; “Do you feel better than before?” at the four-week 
post-discharge out-patient consultation. Of those, n=171 (60%) answered “yes, feeling better”, 
n=73 (26%) answered “no, feeling worse”, and n=41 (14%) answered “no change”. Differences in 
scores on the EQ-5D Index, EQ-5D VAS and the KCCQ on the three different answers of the 
anchor-based approach are presented in Figure 4.  
ROC curves for the predictive effect of the EQ-5D and the KCCQ on the anchor-based outcome are 




EQ-5D VAS, AUC was 0.674 (95% CI 0.598;0.750). For the KCCQ, the AUC was 0.722 (95% CI 
0.651;0.792) (Figure 5). Further diagnostic accuracy measures are presented in the supplementary 
table, S1. 
Health-related quality of life and the risk of readmission 
HRQoL scores preoperatively and at discharge were not associated with 180-day readmission in 




In this prospective study, we investigated HRQoL preoperatively, at discharge and after four weeks 
of discharge after open heart valve surgery. Furthermore, we compared the performance of the two 
instruments EQ-5D and KCCQ, and investigated the association between HRQoL and 180-day 
readmission. We found that patients report worse HRQoL at discharge compared with the pre-
operative scores, but for many patients the score improves at follow-up. Patients undergoing open 
heart valve surgery experienced clinical and statistical improvements in HRQoL measured with the 
EQ-5D VAS and the KCCQ, and nearly half of the patients experienced a moderate or large 
improvement within the first month after discharge. However, we also found a great variation 
within the individual scores and found that despite overall improvements, up to 42% of the patients 
report worse scores after four weeks. This indicates that patients do not derive the full effect of the 
surgery four weeks after discharge. The results of the current study were not unexpected, as 
previous studies also suggest similar findings; lower HRQoL immediately after surgery, at 
discharge and within the first week after discharge, but increasing scores within the first month 
[28,29]. Combined, the studies demonstrate how the early post-operatively period is a seemingly 




on what to expect of the pathway after surgery – especially those with mild symptoms. However, 
the present study also highlight the difficulty in turning data on HRQoL on a group level into an 
individual level as they reflect a summary of scores with a commonly wide distribution within 
individual scores [30]. Information on group level can be used to set a threshold of changes over 
time by investigating the minimal clinically important difference [30]. In the current study, the 
findings add to the current literature, by the presentation of the proportion of patients experiencing 
minimal clinically important differences. This information could potentially be incorporated into 
discharge planning to ensure that patients have realistic expectations when returning home. 
Similarly, our findings indicate that we still need more information to point out the best time-point 
to measure HRQoL if chosen as an outcome in future clinical trials, as current studies include 
measures at different timepoints [7,5].   
When comparing HRQoL among patients undergoing open heart valve surgery with patients 
undergoing transcatheter aortic valve replacement (TAVR), patients undergoing TAVR have 
significantly better HRQoL in the early period after the procedure [31]. This might be explained by 
the minimally invasive approach (compared to sternotomy), early mobilization, a shorter length of 
stay, fewer restrictions and less pain [31]. Thus, the lower HRQoL immediately after open heart 
valve surgery seems to be affected by surgical trauma, the subsequent restrictions and the increased 
risk of complications and readmissions [3,17].  
In the present study we compared EQ-5D and KCCQ with the simple anchor-based question. This 
demonstrated how the KCCQ had a slightly better performance based on the ROC curves and the 
AUC, compared with the EQ-5D. However, it could still be discussed whether any of the 
instruments fully capture how the patient perceives their health status compared with the simple 
approach. The results indicate that the current instruments might not be appropriate measurements 




with aortic stenosis undergoing TAVR and was found to be a reliable, responsive and valid measure 
of HRQoL after TAVR [13]. But as previously discussed, changes in HRQoL seem to be different 
among patients undergoing TAVR compared to patients undergoing open heart valve surgery, 
suggesting that it is important in future research to further validate the KCCQ specifically for 
patients undergoing open heart valve surgery.  
Finally, we did not find HRQoL to be associated with readmission in our population, which is in 
line with a previous study from our group [5]. Although several studies have highlighted how low 
HRQoL is associated with worse long-term outcomes (e.g. mortality, morbidity) in other cardiac 
populations [14,32], this is not demonstrated in patients undergoing open heart valve surgery. A 
possible explanation for the differences might also be related to the surgical procedure with specific 
complications, physical symptoms, changed bodily awareness and the sound of a “clicking valve”in 
patients with mechanical prostheses. This is all issues that likely influence HRQoL, as many of 
these complications arise after discharge [4,8,33]. Thus, the association with readmission can be 
difficult to demonstrate, and the use of patient-reported outcomes at discharge might not be an 
appropriate predictor of future readmission in a surgical population. Also, among patients 
undergoing PCI, findings from a recent qualitative study indicate that undergoing a procedure 
influences how patients perceive the seriousness of the condition compared to receiving medical 
treatment [34]. These findings combined suggest that undergoing a major procedure or surgery 
impact HRQoL.  
 
Limitations  
Our findings should be interpreted in the context of potential limitations. First of all, despite a high 
response rate, there is still a risk of potential non-response bias. When investigating baseline 




were generally in a higher NYHA class. Thus, HRQoL might be lower among non-responders. 
Moreover, missing data within the included instruments might also be a limitation when 
investigating HRQoL. Missing data within the different sum-scores of the instruments were present 
for 5-7% and lower for the clinical variables (2-3 %).  
Another potential limitation of the chosen instruments is whether the responsiveness was sufficient 
to detect changes among patients undergoing open heart valve surgery. None of the above 
instruments were developed specifically for patients undergoing open heart valve surgery. Thus, it 
is unclear whether they capture all aspects that can affect overall health status, mental status and 
HRQoL after open heart valve surgery. Similarly, considerations of potential “floor and ceiling 
effects” should also be considered when investigating the use of patient-reported outcomes [35]. 
Floor and ceiling effects indicate how patients cannot be worse than the worst category or better 
than the best category. Ceiling effects exist on both instruments, which indicate that the instruments 
might not be appropriate and might not have the ability to capture possible changes in outcomes 
among patients undergoing open heart valve surgery if present. For instance, other areas currently 
not measured could involve symptoms of pleural- and pericardial effusions, symptoms of rhythm 
disorders, warning signs of wound infections and concerns on the noise of the valve (e.g., a 
mechanical “clicking sound”). This and the areas of awareness after surgery, as mentioned above, 
should be taken into consideration when investigating and using patient-reported outcomes 
following open heart valve surgery. Similarly, as the effect of the surgery is not fully present among 
all patients at four weeks after discharge, future studies should include a longer follow-up. 
Finally, the lack of observed associations between HRQoL and readmissions could be related to the 






Undergoing open heart valve surgery influences HRQoL measured with the EQ-5D and KCCQ in 
especially the early period after discharge. More than one-third of the patients experience worse 
HRQoL one month after discharge compared with pre-operative scores. The EQ-5D and KCCQ 
have a moderate correlation with how patients perceive their health status four weeks after 
discharge but were not associated with readmission.  
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Figure 1. Flowchart of included patients 
*Responders of T0 and T2 
**Responders at all time points, T0, T1 and T2  
 
Figure 2. Changes in scores from baseline to discharge and four weeks after discharge on the EQ-5D and 
KCCQ 
 
Differences in mean scores at different time points tested with a paired t-test, for difference in median scores, 
see table 2. 
 
Figure 3. Temporal changes in categorical thresholds within each sub-scale of the EQ-5D Index and the 
KCCQ 
 
Figure 4. Differences in patient-reported outcomes scores on the anchor-based approach 
 
Illustrated is differences in scores on the EQ-5D Index, EQ-5D VAS and the KCCQ among patients with the 
answers “Yes, feeling better”, “No, feeling worse” or “No change” to the anchor-based question regarding 
change in condition from before surgery.  
Figure 5. The predictive effect of EQ-5D and KCCQ on the anchor-based question of “Do you feel better 
than before surgery?”  
Receiver operation characteristic (ROC) curves for the predictive effect of the SF-12 and the EQ-5D on 
readmission.  









Sex (male, n (%)) 204 (70) 
Age (median (IQR)) 70 (64-75) 
Living alone (n (%)) 72 (25) 
Pre-operative characteristics and comorbidity  
Chronic obstructive pulmonary disease
 
(n (%)) 40 (14) 
EuroScore II (logistic) (median (IQR)) 1.97 (1.11-3.37) 
Estimated glomerular filtration rate ml/min.
a 
(median (IQR)) 75 (60-99) 
Prior percutaneous coronary intervention (n (%)) 23 (8) 
Hypertension (n (%)) 149 (48) 
Family history of ischemic heart disease (n (%)) 65 (21) 
Prior cardiac surgery (n (%)) 15 (5) 
Permanent pacemaker prior to surgery (n (%)) 9 (3) 
Atrial fibrillation (n (%)) 60 (21) 
Diabetes
b
 (n (%)) 37 (13) 
Ejection fraction ≤50% (n (%)) 83 (29) 
NYHA class ≥3 (n (%)) 92 (32) 
Body Mass Index (median, (IQR)) 26 (24-29) 
Current or former smoker (n (%)) 172 (59) 
Alcohol intake above national recommendations (n (%)) 35 (12) 














Type of valve procedure, (n (%)) 
Aortic valve, biological 
Aortic valve, mechanical 
Aortic valve, repair 
Mitral valve, replacement
d 







Concomitant CABG (n (%)) 65 (22) 
Re-operation (n (%)) 25 (9) 
New onset atrial fibrillation, postoperatively (n (%)) 130 (45) 
Length of stay (median (IQR)) 9 (7-12) 
a Estimated glomerular filtration rate estimated by the Cockcroft-Gault Equation. 
b Patients with diabetes; insulin, per oral and non-pharmacological treatment. 
c One patient had tricuspid valve disease and are not shown in the table, but included in the analyses 
d Both biological and mechanical mitral valve replacement 


























































*Due to two-weeks recall of the KCCQ, only EQ-5D was completed at discharge 
†






Table 3. Association between HRQoL and 180-days readmission  

































The table shows the association between the scores of EQ-5D and KCCQ and risk of readmission. 
All sub-scales of the KCCQ were tested, showing the same results 
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Supplementary table S1 
 Formula EQ-5D Index EQ-5D VAS KCCQ 
  n n n 
N  163 170 202 
True positive, TP - 73 93 111 
False positive, FP - 18 23 29 
False negative, FN - 49 33 35 
True negative, TN - 23 21 27 
  Estimates Estimates Estimates 
Sensitivity, Se TP / (TP+FN) 0.60 0.74 0.76 
Specificity, Sp TN / (TN+FP) 0.56 0.48 0.48 
Positive predictive value, PPV TP / (TP+FP) 0.80 0.80 0.79 
Negative predictive value, NPV TN / (TN+FN) 0.32 0.39 0.44 
Positive likelihood ratio, PLR Se / (1-Sp) 1.36 1.41 1.47 
Negative likelihood ratio, NLR (1-Se) / Sp 0.72 0.55 0.50 
Diagnostic Odds Ratio, DOR PLR / NLR 1.90 2.57 2.95 
Accuracy index, AI (TP+TN) / (TP+TN+FP+FN) 0.59 0.67 0.68 
Youdens index, YI Se + Sp - 1 0.16 0.22 0.24 
Patients with missing scores or patients experiencing similar outcomes as before surgery were not included in the 
calculation of the  
diagnostic accuracy measures 
 
